Everyone knows they have 0 cash. Just do it already!!!!
How bad is this for VZ?
So, now we know it was not MAPP, we know it was not SRPT because they said so. And now we know it was not a blood transfusion. Why make this more complicated than it is. Dr. Sarca was given TKMR and feels better.
While the experimental drug, ZMapp, used to treat two other Ebola patients at Emory Hospital is no longer available, Sacra is receiving a research drug.
"After talking with people at Emory and the CDC, we were able to determine a drug that had some promise." Smith would not comment more about the unnamed experimental drug.
Doctors are considering a blood transfusion from survivors of Ebola. Sacra has not yet received one.
The whole aero space small cap sector exploding. I don't' think it is late to get into MRCY as it hardly has moved. Plus, it is the only real aero space among those and a rumored GE buyout. I don;'t know. Look for volume to explode
How many bulletin board stocks have Leon invested in? The terms must be the same as where insiders did the deal .155 and 1/2 warrant coverage. I see new highs coming....
Stock is getting monkey hammered.. poor retail.....
With the merger, which will undoubtedly go through, the number of shares outstanding is approximately 30 million. Unlike most biotech companies, the merged company actually has revenues, 17.5 million and about 7 million in cash. The Phase Ib results were very impressive and the market they are looking to serve is a billion dollar market. The P value demonstrates that the results were unlikely random. Of course the patient population was small and it was single site subject to investigator bias but the company will explain more about that on Monday after the close. Regardless, the data is extremely impressive and for this reason they holding a CC on Monday after the close. Just based on the P1b results the company should have a market cap of 100 million similar to peers or about 3.30 a share. Prior to the merger, ThermoGenesis was trading at it's lows around a dollar. Through the dollar on top of the 3.30 and you are at 4.30. This says nothing about the pipeline and the underlying business. Look for a run to 4 dollars next week.
One I am not a doctor and neither are most of you. It is easy to reiterate the company narrative. It is better to follow the money. See what happens tomorrow. It is setting up for another dump day. If volume comes in and they take it higher I would jump on board. But I think the "smart" money is getting out before the results. Look for 5.45 as support as that is the 50 day. If it breaks that then 4 bucks. Strange nest ce pas that it is down another 5% AH? Secondary coming? I don't know. I just know it looks broken for now
If you listen to Tanzi interview he is alluding to this ....
You have 3 times average volume about 2 weeks from results stock closing on its low.. what does that tell you....
Despite the company's incessant assertions to the contrary, it is clear the FDA does not want Heplisav. They have frustrated the company at every turn. The company said back in June that in a few weeks the protocol for the new trial would be set. It has been 3 months. Each month the company burns through more and more cash and still no word on the trial and the number of patients and the protocol. Per the company's statement you are looking at about 3 years before the trial once commenced would be completed. Their patents by this time will have only a few years left. Now they put out some release on their asthma drug which is so far away it is essentially meaningless. The question is when will they raise money again ... I think it goes sub 1 in the next week on capitulation selling as this story is just so old and tired.
What are we missing? Why does this pos stay here at multi year lows? Any ideas? Is it because nobody has any faith in Linda and management? Is it because smarter people than we have looked into this and found nothing to DCVax-Direct and DCVax-l will take a few more years for enrollment? What is the problem with this company because you have to be honest it trades horribly....
Monday morning imagine CNBC... This just in. Google the world's larges search engine has just be found guilt of patent infringement regarding their search algo. Damages have been awarded amounting to 7% of 20% of all US Ad Word Search Revenue. Experts report this could amount to over a billion dollars. The recipient of the award is a little heretofore unknown ringtone company with a market cap of less than 350 million... TRIPLE